Should you Invest in the Latest Sovereign...
For the uninitiated, sovereign gold bonds can be understood to be certificates issued and mandated by the Reserve Bank of India.
Transform from Learner to Earner.
Open FREE* Demat Account23 Jul, 2021
8 min read
2017 Views
This high amounts to a 5 percent increase which is eye-catching as the market has otherwise been pretty subdued. This is the eighth consecutive trading day that has witnessed a consecutive rise in the price of the stock of Laurus Labs. This falls in sharp contrast to the S&P BSE Sensex which was down 01.7 percent and held 52,237 points at 10:10 AM the same day.
Headquartered in Hyderabad, Laurus Labs is at the forefront of research-driven pharmaceutical manufacturing taking place in the country today. It manufactures a wide range of medical products including an active pharmaceutical ingredient (or API) which is used for gastroenterological, anti-asthma related, antidiabetic, cardiovascular, and oncology-related purposes. Laurus Labs is taking advantage of the opportunities for growth available to formulation manufacturing services in leading markets situated in North America and Europe in addition to those present in low- and middle-income countries (or LMIC).
Growth opportunities that Laurus Labs has been taking advantage of include those pertaining to contract development and manufacturing (or CDM) with the aid of its synthesis business. A large chunk of Laurus Labs’ manufacturing facilities have the approval of leading regulatory authorities including but not limited to WHO based out of Geneva, UK’s MHRA, and America’s FDA.
Laurus Labs has under its umbrella a team of over 3000 individuals who are geared towards expanding the frontiers of chemistry such that new cures can be developed while building a profitable business operation. Laurus Labs team is made up of a wide range of professionals that include research scientists, those involved in manufacturing and management in addition to veterans within the pharmaceutical industry.
Laurus Labs has manufacturing units located in Bengaluru, Hyderabad, and Visakhapatnam.
Since April, Laurus Labs has consistently stayed ahead of the curve on the market and has surged by 73 percent following the company’s promoters releasing a large number of the pledged shares by selling the shares that they held. This stands in sharp contrast to the S&P on the BSE Sensex which was up 3.7 percent for the same time frame.
Information pertaining to the shareholding pattern highlights only 1.15 percent of the total promoters’ holdings being pledged as of March 31 this year. This can be set against the holding pledged at the conclusion of the December 2020 quarter which amounted to 15.76 percent.
The founder and promoter holding the positions of CEO & ED, Dr. Satyanarayana Chava of Laurus Labs and Nagarani Chava, one of the key promoters in charge, collectively sold shares amounting to 7 million in number to the tune of INR 258 crores via the open market on March 4 this year.
In addition to this, the management responsible has outlined a CAPEX amounting to INR 1,500 Crores which is applicable over the next two years. Of this 50 percent is to be invested in the active pharmaceutical ingredient or API industry, 30 percent is to be directed towards the finished dosage forms (or FDF) industry and 20 percent is to be funneled towards the contract development and manufacturing organization (CDMO) segment.
Laurus Labs maintains confidence in terms of accruing a 30 percent EBITDA margin for the financial year 2022. Details pertaining to debottlenecking within the fixed dosage formulations (or FDF) have been dealt with as of March this year and the commercial benefits from the same are expected to deliver within the first half of 2022’s financial year. New manufacturing blocks are expected to be commercialized by September this year.
Laurus Labs seeks to add capacity to cater to non-antiretroviral (or ARV) active pharmaceutical ingredient products which are expected to be commercially accessible by the end of 2022’s financial year. This implies meaningful growth is likely following 2023’s financial year. Following 2023’s financial year, Laurus Labs is likely to witness growth and expansion within the synthesis business which contributes 11 percent of its sales. Moreover, this is expected to surpass growth within the active pharmaceutical ingredient / fixed dosage formulations segment, keeping in mind active projects and the added capacity.
Analysts believe that Laurus Labs is likely to remain victorious owing to its superior capabilities within the antiretroviral sphere. This interspersed with its superior knowledge of chemistry which governs the contract development and manufacturing organization set up and their addition of molecules to the other API segment is beneficial. Laurus Labs also stands to be cost-efficient in its operations which will continue to enhance its profits. It has created new levels within the contract development and manufacturing organization (CDMO) segment with the aid of Laurus Bio.
As per Laurus Labs website, it provides consumers with affordable and high-quality APIs that have been manufactured keeping in mind the highest good manufacturing practice standards. Their innovative FDFs have been made possible with the aid of world-class research endeavors. Their website also highlights their use of natural and nature-identical ingredients that are employed to enhance overall well-being.
What makes Laurus Labs stand out is its commitment to transparency and integrity. These values have helped it attract the best in its field and have helped it secure the trust of its stakeholders. Owing to the fact that Laurus Labs operates within a sector that is extremely regulated, it has adopted a high-watermark approach to compliance such that it can surpass the requirements set forth by international standards.
Q1. What industry does Laurus Labs operate within?
A1. Laurus Labs operates within the pharmaceutical industry and manufactures a wide range of medical products including an active pharmaceutical ingredient (or API).
Q2. Why do analysts think Laurus Labs is likely to be successful in the long run?
A2. Analysts believe that Laurus Labs is likely to remain successful due to its superior capabilities within the antiretroviral sphere.
Q3. What is API and why is it important?
A3. Active pharmaceutical ingredient (or API) is a medical product that is used for gastroenterological, anti-asthma-related, antidiabetic, cardiovascular, and oncology-related purposes.
How would you rate this blog?
Related Blogs
Translate the power of knowledge into action. Open Free* Demat Account
30 Aug, 2021
7 min read
Should you Invest in the Latest Sovereign...
For the uninitiated, sovereign gold bonds can be understood to be certificates issued and mandated by the Reserve Bank of India.
27 Jan, 2021
9 min read
HDFC Bank Ltd’s Journey to becoming the...
As of November 25, 2020, HDFC Bank had hit a market cap of ₹8 Lakh Crore and had become the third company to do so after Reliance and TCS.
04 Apr, 2021
7 min read
Dr. Reddy's Laboratories Ltd - Is this...
2020 was a peculiar year, especially in terms of the industries that managed to flourish despite the challenges that the lockdowns and isolation meas…
07 Jul, 2021
10 min read
Ixigo IPO: Ixigo Plans a 750 Crore IPO
Ixigo is a travel portal and it plans to host an IPO of between Rs 1500 crore to Rs 1800 crore later this year.
06 Oct, 2021
5 min read
Byju’s IPO Plans
Currently, India's most valuable unicorn, online education provider Byju's, is in talks to raise $400 million to $600 million and then expedite plans…
15 May, 2021
8 min read
The Best Penny Stocks in India
Investing and trading on the stock market has the potential to generate profits.
15 Jun, 2021
10 min read
A sneak peek at Zomato's IPO plans
Covid-19 came and turned the world upside down – tourism, airlines, fashion, F&B have suffered tremendously but online financial gateways, video conf…
08 May, 2021
8 min read
Adani Ports and its recent rise. Here's why
If you have been following the rise of Adani Ports’ stock price in recent weeks, you are probably curious as to what is driving this growth.
11 Jul, 2021
11 min read
Go Air IPO: Go Air looks to enter the IPO market
GoAir, one of India’s most popular airlines, is preparing for an initial public offering (IPO). Rebranding itself as “Go First”, the airline filed a …
01 Apr, 2021
7 min read
Vodafone-Idea: What went wrong?
Mergers and acquisitions can turn the eyes of stock market investors towards the possible action that such large-scale actions can bring to the futur…
11 Jun, 2021
7 min read
Stock Picks Based on Q4 Results
As FY21 drew to a close, it was a déjà vu moment as lockdowns (although state-level), and a second wave of the COVID-19 pandemic defined investor beh…
28 Dec, 2020
6 min read
The Rise of Reliance: as told through its stocks
Reliance Industries Limited (RIL) is India’s largest publicly traded company. Read on to know more about history of Reliance stocks and it’s rise in …
24 Aug, 2021
5 min read
Stocks to Watch: NMDC, Tata Motors,...
This article seeks to shed light on stocks that have recently been made available in the market. Included among them is the government’s stake in NMD…
08 Jul, 2021
10 min read
The Success Story of Pharmeasy
Today, PharmEasy is a reputable and well-known firm whose aim is to become the best health care delivery platform in India.
10 Mar, 2021
7 min read
PVR - a comeback on the cards?
Who doesn’t like to watch movies. But when the COVID pandemic first hit the Indian subcontinent, investors began to withdraw from their investments -…
24 Feb, 2021
7 min read
Shree Cements: A lesson in Prudence
This article will help you take a deeper look into the rise of Shree Cements, through the lens of it’s stock performance over the past few years.
07 Apr, 2021
7 min read
The Tata Motors Upheaval Story
The automotive industry has been famously tied to the performance of the extended economy for most countries.
13 Oct, 2021
6 min read
LIC Seeks to Appoint CFO
According to a notice on its website, the state-owned Life Insurance Corporation of India (LIC) is looking for a Chief Financial Officer ahead of an …
21 May, 2021
8 min read
Asian Paints: 7000% returns in 17 years
Some investment propositions have the ability to make investors – both the newbie and the expert alike – stop and stare.
24 Sep, 2021
7 min read
Indian Railways Share Quarterly Results -...
The Indian Railway Catering and Tourism Corporation (IRCTC) is a subsidiary of the Indian Railways.
31 May, 2021
7 min read
The Rise of Metal Stocks Amid the 2nd Wave
The past few months have brought with them several changes.
29 Oct, 2021
7 min read
Sugar Stocks Down as Sensex Falls
Sugar stocks are indicative of important trends in the market. They are also an important cog in the industries sector of the economy. Read on to kno…
06 May, 2021
9 min read
Should you place your bets on ITC?
Investors trading on the stock market are advised to focus on maximising their wealth by making shrewd decisions based on the performance and fundame…
06 Jan, 2021
6 min read
Tata Consultancy Services: A story...
Tata Consultancy Services (TCS) is the world’s most valuable IT company. Read this success story of how TCS expanded globally, acquired new verticals…
09 Jul, 2021
9 min read
IPO Alert! Devyani International files...
Against all odds, the Indian market, despite a minor tailspin due to the nationwide lockdowns last year, has seemed to recover relatively well.
05 Mar, 2021
7 min read
The LIC IPO Game Plan
IPOs have attracted overt attention of retail and institutional investors alike in the recent Indian stock market scene.
23 Aug, 2021
6 min read
Clean Science, GR Infraprojects IPO...
This article seeks to shed light on initial public offerings (or IPOs) that have recently been up for grabs in the market. Included among them are Cl…
13 Jun, 2021
7 min read
Soaring commodity prices. Here's why
Prices of commodities in the energy, metal and agriculture sectors have seen a sustained rise in the first few months of this year.
03 Jun, 2021
6 min read
Hotel Stocks on the Rise Despite Lockdown
The hospitality industry suffered a major setback when the prime minister announced a nationwide lockdown for 3 weeks at the end of March 2020.
01 Jun, 2021
8 min read
Muted Tata Communications stock in wake...
There is a meme going around that says: Sneezes went from “Bless you” to “To hell with you” real soon.
05 Oct, 2021
7 min read
LIC IPO: All we Know So Far
While investors await the Life Insurance Corporation's mammoth public offering mostly happening this financial year, why do experts think the IPO has…
16 Mar, 2021
8 min read
Indiamart’s QIP: behind the scenes
Last year, when the pandemic had hit businesses hard across the globe, most people resorted to the internet to keep their businesses afloat.
Subscribe to #SmartSauda Newsletter
The hindi feature is coming soon!
The hindi feature is coming soon!
Contact Support
You will not be able to access your Smart Money Account
Report Issue
Share this page
×Hey, I have discovered this amazing financial learning platform called Smart Money and am reading this blog on . You can explore too.
Link Copied